The AI Dates conference dedicated to artificial intelligence and the fight against cancer was held this Monday, October 19. Professors Paul Hofman and Olivier Humbert presented the prospects of AI for improving screening, analyzing medical data and advancing research.
Can artificial intelligence help detect cancers earlier and accelerate medical research? This question was at the heart of the conference “Cancers: AI in the service of research and screening”, organized as part of the AI Dates of the Alpes-Maritimes Department.
Charles Ange Ginésy, president of the Alpes-Maritimes department, of the Joint Syndicate of the House of Artificial Intelligence and SICTIAM, participated in this meeting led by professors Paul Hofman and Olivier Humbert. Organized in collaboration with several stakeholders in the fight against cancer, making sense during this period of Breast Cancer Awareness Month, the conference presented various applications of artificial intelligence in the medical field.
AI to improve screening and accelerate cancer research
The two speakers presented their respective work, which integrates artificial intelligence in the study of cancers. Professor Olivier Humbert is notably developing a communication network designed to analyze massively the information collected during medical examinations, while preserving patient anonymity.
For his part, Professor Paul Hofman presented an overview of the new challenges linked to artificial intelligence in healthcare facilities. The conference notably addressed multimodal artificial intelligence approaches, referred to as Multimodal AI (MMAI).
These technologies open perspectives for the exploitation of medical data and the development of new analysis methods. The objective is notably to contribute to better detection of cancers and to support research work. Their use must however be part of a framework that preserves data confidentiality and maintains the expertise of healthcare professionals at the center of care provision.
The meeting was organized with the Antoine Lacassagne Center, the Provence-Alpes-Côte d’Azur Cancer Hub, the IHU RespirERA Côte d’Azur and the Mozart Institute, several stakeholders involved in cancer research and prevention.
On the occasion of this conference, Charles Ange Ginésy recalled the place of humanity in the development of these technologies. “AI will never replace healthcare professionals: it must remain a powerful tool in the service of medical expertise and humanity”, declared the president of the Alpes-Maritimes department.
AI Dates, a series of conferences dedicated to artificial intelligence issues
This conference is part of the SMART Deal, the policy of the Alpes-Maritimes department dedicated to digital transformation. Through AI Dates, the local authority wishes to enable the general public to better understand developments related to artificial intelligence and their consequences in daily life.
These meetings take the form of conferences and round tables dedicated to different fields, including health, mobility, ethics and territories. The series is co-organized with the House of Artificial Intelligence, SICTIAM and the EuropIA Institute.
The stated ambition is to promote access to technological innovations and reduce inequalities in access to care. In the field of cancer prevention, applications of artificial intelligence thus constitute a research avenue for improving medical practices, while keeping healthcare professionals at the heart of the patient’s journey.
NicePremium is a free, independent local news outlet.
Help us keep going by supporting our work from €5 per month.
